Enorna Biotechnology
PrivateCompany Overview
Enorna Biotechnology is an mRNA CRDMO company that provides end-to-end solutions from sequence design to commercial GMP manufacturing of plasmid, mRNA, and LNP drug products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
nucleic acid therapeuticsCRDMOCDMOmRNA synthesisLNP encapsulationplasmid DNAGMP manufacturingbiotech outsourcingCMC developmentlipid nanoparticlesLNPdrug development servicesbiopharma manufacturingfill and finishanalytical testingbiotech supply chain
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enorna Biotechnology Comparables
Compare Enorna Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kudo Biotechnology | 92% | |
| Vernal Biosciences | 83% | |
| ARCALIS, Inc. | 83% | |
Enorna Biotechnology Funding Rounds
Historical fundraising activity
Enorna Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enorna Biotechnology's valuation, stock price, and market status.
See something wrong or outdated?